🇺🇸 FDA
Patent

US 7825096

O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

granted A61PA61P35/00

Quick answer

US patent 7825096 (O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P35/00